Showing results (411-420 of 452) with videos related to

Sort By:
Pageof 46
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2011
First-in-man study of CPX-351: a liposomal carrier containing cytarabine and daunorubicin in a fixed 5:1 molar ratio for the treatment of relapsed and refractory acute myeloid leukemiaEric J Feldman, Jeffrey E Lancet, Jonathan E Kolitz, et al.
Current Drug Metabolism|January 6, 2016
Investigating ABCB1-Mediated Drug-Drug Interactions: Considerations for In vitro and In vivo Assay DesignZsolt Sáfár, Balázs Vaskó, Tasha K Ritchie, et al.
Current Biology : CB|February 7, 2017
Circadian Entrainment to the Natural Light-Dark Cycle across Seasons and the WeekendEllen R Stothard, Andrew W McHill, Christopher M Depner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2006
Phase I/II study of continuous-infusion troxacitabine in refractory acute myeloid leukemiaGail J Roboz, Francis J Giles, Ellen K Ritchie, et al.
Leukemia & Lymphoma|November 26, 2019
Consolidation outcomes in CPX-351 versus cytarabine/daunorubicin-treated older patients with high-risk/secondary acute myeloid leukemiaJonathan E Kolitz, Stephen A Strickland, Jorge E Cortes, et al.
Journal of the American Chemical Society|August 28, 2010
A metal-organic framework with a covalently prefabricated porous organic linkerShashikala I Swamy, John Bacsa, James T A Jones, et al.
Pageof 46